AI agent-based discovery of antimicrobial peptides against multidrug-resistant gram-negative bacterial infection.
In the sepsis mouse model, AMP-ZJLC586 significantly increased the survival rate by 65%, effectively suppressed the level of inflammatory factors, improved organ damage, and reduced the bacterial load of target organs by 103-104 CFU/g, highlighting its great therapeutic potential.